BioGaia AB (LTS:0GTN) Days Sales Outstanding : 32.44 (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is BioGaia AB Days Sales Outstanding?

BioGaia AB's average Accounts Receivable for the three months ended in Dec. 2023 was kr106 Mil. BioGaia AB's Revenue for the three months ended in Dec. 2023 was kr298 Mil. Hence, BioGaia AB's Days Sales Outstanding for the three months ended in Dec. 2023 was 32.44.

The historical rank and industry rank for BioGaia AB's Days Sales Outstanding or its related term are showing as below:

LTS:0GTN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 33.3 Med: 50.28 Max: 59.01
Current: 33.3

During the past 13 years, BioGaia AB's highest Days Sales Outstanding was 59.01. The lowest was 33.30. And the median was 50.28.

LTS:0GTN's Days Sales Outstanding is ranked better than
85.6% of 1000 companies
in the Drug Manufacturers industry
Industry Median: 71.68 vs LTS:0GTN: 33.30

BioGaia AB's Days Sales Outstanding declined from Dec. 2022 (43.48) to Dec. 2023 (32.44).

BioGaia AB Days Sales Outstanding Historical Data

The historical data trend for BioGaia AB's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioGaia AB Days Sales Outstanding Chart

BioGaia AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

59.01

54.58

50.46

41.21

33.30

BioGaia AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															43.48	32.60	-	-	32.44

Competitive Comparison of BioGaia AB's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, BioGaia AB's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioGaia AB's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioGaia AB's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where BioGaia AB's Days Sales Outstanding falls into.

BioGaia AB Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

BioGaia AB's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (130.703	+	105.875)	/	2 )	/	1296.505	*	365
=	118.289					/	1296.505	*	365
=	33.30

BioGaia AB's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0	+	105.875)	/	1 )	/	297.773	*	365 / 4
=	105.875					/	297.773	*	365 / 4
=	32.44

BioGaia AB (LTS:0GTN) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

BioGaia AB Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of BioGaia AB's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

BioGaia AB (LTS:0GTN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioGaia AB (LTS:0GTN) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

BIOGY:USA BGLAF:USA BIOG B:Sweden BGLA:Germany

Address

Kungsbroplan 3A, Stockholm, SWE, SE-112 27

Website

https://www.biogaia.se

BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions; Asia Pacific, Europe, the Middle East, Africa, and the Americas.

BioGaia AB (LTS:0GTN) Headlines

No Headlines